Operating Lease, Payments in USD of Sigyn Therapeutics, Inc. from 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Sigyn Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and change rate from 2021 to Q1 2025.
  • Sigyn Therapeutics, Inc. Operating Lease, Payments for the quarter ending 31 Mar 2025 was $19.5K, a 3% increase year-over-year.
  • Sigyn Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $77.1K, a 42.2% increase from 2023.
  • Sigyn Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $54.3K, a 25.4% decline from 2022.
  • Sigyn Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $72.7K, a 307% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

Sigyn Therapeutics, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $19.5K +$568 +3% 01 Jan 2025 31 Mar 2025 10-Q 20 May 2025
Q1 2024 $19K +$552 +3% 01 Jan 2024 31 Mar 2024 10-Q 20 May 2025
Q1 2023 $18.4K +$536 +3% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q1 2022 $17.9K 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023

Sigyn Therapeutics, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $77.1K +$22.9K +42.2% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 $54.3K -$18.5K -25.4% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 $72.7K +$54.8K +307% 01 Jan 2022 31 Dec 2022 10-K 20 Feb 2024
2021 $17.9K 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.